PMID: 8948299Nov 1, 1996Paper

Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population

British Journal of Rheumatology
C BryanA Silman

Abstract

Scleroderma is a multisystem disease which in many populations is reported to have a substantially reduced survival. One problem with many of the published studies is the inclusion of patients with differing lengths of disease at baseline, with the possibility of left censorship bias. The aim was to determine the survival and its predictors in a cohort of scleroderma patients with new onset of disease. All 283 new patients referred to one of the authors (CMB) who had a reported disease onset after 1 January 1982 were studied. Detailed clinical and laboratory information at baseline and at 1 yr were extracted from the structured records. Vital status as at 1 December 1993 was determined using the UK's NHS Central Register. Expected numbers of deaths were obtained by applying local age and sex all-cause mortality rates. In total, there were 1871 person-years of follow-up with crude mortality rates of 3.9 and 2.6%/year, respectively, in males and females. The mortality rate remained approximately constant over the first 10 yr of follow-up. In comparison with expected survival, based on the age distribution of the cohort, there was an overall 4-fold increased mortality rate in this group which was higher in females [standardized mo...Continue Reading

Citations

Nov 15, 2002·International Journal of Hematology·Richard K BurtAlberto M Marmont
May 11, 2010·Clinical Rheumatology·Paola CaramaschiDomenico Biasi
Jul 3, 2013·Clinical Rheumatology·Gemma StricklandNeil McHugh
Oct 6, 2011·Nature Reviews. Rheumatology·Robyn T Domsic, Thomas A Medsger
Dec 17, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·S Jablonska, M Blaszczyk
Jun 12, 2009·Rheumatology·C P DentonU Müller-Ladner
Mar 13, 2010·Rheumatology·Carmen Pérez-BocanegraMiquel Vilardell-Tarrés
Jan 30, 1999·Annals of the Rheumatic Diseases·R HesselstrandA Akesson
Jan 11, 2000·Annals of the Rheumatic Diseases·M HoJ Belch
Apr 28, 2000·Annals of the Rheumatic Diseases·P G VlachoyiannopoulosH M Moutsopoulos
Jan 15, 2003·Annals of the Rheumatic Diseases·C MorganA J Silman
Dec 22, 2011·International Journal of Rheumatology·Cristina RigamontiAndrew K Burroughs
Feb 19, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Moshe Levy, Adi Rizansky
Sep 3, 2014·La Presse médicale·Edoardo SavarinoVincenzo Savarino
Feb 14, 2004·Rheumatology International·Paola CaramaschiLisa Maria Bambara
Oct 25, 2014·Annals of the Rheumatic Diseases·Muriel ElhaiUNKNOWN EUSTAR co-authors
Jan 20, 2016·The Journal of Dermatology·Koichi Yanaba
Aug 19, 2008·Seminars in Arthritis and Rheumatism·Firas F Al-DhaherJanine M Ouimet
Jan 29, 2008·Seminars in Arthritis and Rheumatism·Y Stephanie GuM Eric Gershwin
Oct 1, 2009·Arthritis and Rheumatism·Shervin AssassiMaureen D Mayes
Mar 5, 2014·Arthritis & Rheumatology·Svetlana I NihtyanovaChristopher P Denton
Jun 27, 2006·Joint, Bone, Spine : Revue Du Rhumatisme·Olivier Meyer
Apr 12, 2016·Rheumatology International·Hadi PoormoghimNazanin Mojtabavi
Mar 11, 2011·Scandinavian Journal of Rheumatology·C-F KuoS-F Luo
Aug 12, 2014·Seminars in Arthritis and Rheumatism·Alfredo Guillen-Del CastilloMiquel Vilardell-Tarrés
Jun 17, 2014·Seminars in Arthritis and Rheumatism·Manuel Rubio-RivasVicent Fonollosa
May 6, 2016·Current Rheumatology Reports·Jessica K Gordon, Robyn T Domsic
Apr 12, 2014·Journal of Clinical Epidemiology·Sindhu R JohnsonDinesh Khanna
Dec 29, 2016·Arthritis & Rheumatology·Yanjie HaoUNKNOWN Australian Scleroderma Interest Group
Jan 11, 2005·The American Journal of Medicine·John P A IoannidisHaralampos M Moutsopoulos
Apr 9, 2011·Angiology·Maurizio Cusmà PiccioneScipione Carerj
Mar 25, 2016·World Journal of Transplantation·Subramanian RamaswamyVinod Ravindran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.